Order Article Reprints

Bromek E, Haduch A, Rysz M, Jastrzębska J, Pukło R, Wójcikowska O, Danek PJ, Daniel WA. The Selective NMDA Receptor GluN2B Subunit Antagonist CP-101,606 with Antidepressant Properties Modulates Cytochrome P450 Expression in the Liver. Pharmaceutics. 2021; 13(10):1643. https://doi.org/10.3390/pharmaceutics13101643

Bromek, Ewa, Anna Haduch, Marta Rysz, Joanna Jastrzębska, Renata Pukło, Olga Wójcikowska, Przemysław Jan Danek, and Władysława Anna Daniel. 2021. "The Selective NMDA Receptor GluN2B Subunit Antagonist CP-101,606 with Antidepressant Properties Modulates Cytochrome P450 Expression in the Liver" Pharmaceutics 13, no. 10: 1643. https://doi.org/10.3390/pharmaceutics13101643

Bromek, E., Haduch, A., Rysz, M., Jastrzębska, J., Pukło, R., Wójcikowska, O., Danek, P. J., & Daniel, W. A. (2021). The Selective NMDA Receptor GluN2B Subunit Antagonist CP-101,606 with Antidepressant Properties Modulates Cytochrome P450 Expression in the Liver. Pharmaceutics, 13(10), 1643. https://doi.org/10.3390/pharmaceutics13101643